Patient Guide: A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 237 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05296798
Status: 🟢 Enrolling Now
Condition: Locally Advanced or Metastatic Breast Cancer
Phase: PHASE3

Where You Can Participate

This study is available at 237 locations across the country.

Top locations include:
  • • Tucson, Arizona
  • • Hot Springs, Arkansas
  • • Los Angeles, California
  • • And 234 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer) - Join Clinical Trial NCTNCT05296798

How to Join This Clinical Trial - NCTNCT05296798

Learn how to participate in this PHASE3 trial studying an investigational therapy for Locally Advanced or Metastatic Breast Cancer. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Locally Advanced or Metastatic Breast Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Locally Advanced or Metastatic Breast Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05296798 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 237 locations. Find a study site near you:

Clinical Research Site

Tucson, Arizona 85715 - United States

Status: RECRUITING

Clinical Research Site

Hot Springs, Arkansas 71913 - United States

Status: WITHDRAWN

Clinical Research Site

Los Angeles, California 90017 - United States

Status: RECRUITING

Clinical Research Site

Grand Junction, Colorado 81502-1628 - United States

Status: WITHDRAWN

Clinical Research Site

Jacksonville, Florida 32256 - United States

Status: RECRUITING

Clinical Research Site

West Palm Beach, Florida 33401-3406 - United States

Status: WITHDRAWN

Clinical Research Site

Urbana, Illinois 61801 - United States

Status: RECRUITING

Clinical Research Site

Annapolis, Maryland 21401 - United States

Status: RECRUITING

Clinical Research Site

Ann Arbor, Michigan 48106 - United States

Status: RECRUITING

Clinical Research Site

Detroit, Michigan 48202 - United States

Status: RECRUITING

And 227 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Locally Advanced or Metastatic Breast Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships